WELLS FARGO & COMPANY/MN - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 44 filers reported holding REPROS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$4,000
+100.0%
6,000
-3.2%
0.00%
Q3 2017$2,000
-33.3%
6,200
-3.1%
0.00%
Q2 2017$3,000
-62.5%
6,4000.0%0.00%
Q1 2017$8,000
+14.3%
6,400
+18.5%
0.00%
Q4 2016$7,000
-36.4%
5,4000.0%0.00%
Q3 2016$11,000
+22.2%
5,4000.0%0.00%
Q2 2016$9,000
+80.0%
5,400
+1.9%
0.00%
Q1 2016$5,000
-28.6%
5,301
-1.9%
0.00%
Q4 2015$7,000
-90.1%
5,401
-43.7%
0.00%
Q3 2015$71,000
+44.9%
9,601
+38.0%
0.00%
Q2 2015$49,000
-33.8%
6,956
-17.8%
0.00%
Q1 2015$74,000
+105.6%
8,466
+137.0%
0.00%
Q4 2014$36,000
+56.5%
3,572
+54.4%
0.00%
Q3 2014$23,000
-32.4%
2,314
+13.9%
0.00%
Q2 2014$34,000
+240.0%
2,031
+246.0%
0.00%
Q1 2014$10,000587
+11640.0%
0.00%
Q4 2013$0
-100.0%
5
-99.8%
0.00%
Q3 2013$85,0003,178
+317700.0%
0.00%
Q2 2013$010.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 978,800$1,292,0000.33%
Allegis Investment Advisors, LLC 344,487$455,0000.14%
GENERAL AMERICAN INVESTORS CO INC 589,768$778,0000.08%
Acrospire Investment Management LLC 23,177$31,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 268,130$354,0000.01%
Alambic Investment Management, L.P. 16,091$21,0000.00%
OXFORD ASSET MANAGEMENT LLP 51,359$68,0000.00%
Renaissance Technologies 716,413$946,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$4,0000.00%
Virtu KCG Holdings LLC 45,144$60,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders